FbaA- and M protein-based multi-epitope vaccine elicits strong protective immune responses against group A streptococcus in mouse model
- 1 May 2014
- journal article
- Published by Elsevier in Microbes and Infection
- Vol. 16 (5) , 409-418
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A Novel Monoclonal Antibody against FbaA Can Inhibit the Binding of the Complement Regulatory Protein Factor H to Group A StreptococcusClinical and Vaccine Immunology, 2011
- Similar Ability of FbaA with M Protein to Elicit Protective Immunity Against Group A Streptococcus Challenge in MiceCellular & Molecular Immunology, 2009
- Recruitment of Complement Factor H-Like Protein 1 Promotes Intracellular Invasion by Group A StreptococciInfection and Immunity, 2003
- Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell MemoryScience, 2003
- Sequence of myosin-crossreactive epitopes of streptococcal M protein.Journal of Experimental Medicine, 1986
- Effect of antibiotic therapy on the clinical course of streptococcal pharyngitisThe Journal of Pediatrics, 1985
- Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein.Journal of Experimental Medicine, 1985
- Multiple, heart-cross-reactive epitopes of streptococcal M proteins.Journal of Experimental Medicine, 1985
- DIFFERENTIATION OF GROUP A STREPTOCOCCI WITH A COMMON R ANTIGEN INTO THREE SEROLOGICAL TYPES, WITH SPECIAL REFERENCE TO THE BACTERICIDAL TESTJournal of Experimental Medicine, 1957
- THE ANTIGENIC COMPLEX OF STREPTOCOCCUS HÆMOLYTICUSJournal of Experimental Medicine, 1928